|
시장보고서
상품코드
2152274
셀 페인팅 시장 규모, 점유율 및 동향 분석 보고서 : 제품 및 서비스별, 세포 유형별, 기술별, 용도별, 최종 용도별, 지역별 및 부문별 전망(2026-2033년)Cell Painting Market Size, Share & Trends Analysis Report By Product & Services (Instruments, Services), By Cell Type (Cancer Cell Lines, Primary Cells), By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
셀 페인팅 시장 요약
세계 셀 페인팅 시장 규모는 2025년에 8억 5,070만 달러로 평가되었고, 2026년 9억 5,960만 달러에서 2033년까지 23억 5,940만 달러로 성장할 것으로 예상되며, 2026-2033년 연평균 성장률(CAGR)은 13.7%를 기록할 것으로 전망됩니다.
2025년에는 북미 시장이 매출 점유율의 39.6%를 차지하며 시장을 주도했습니다. 시장 성장은 고해상도 표현형 프로파일링의 도입 확대, 인공지능 및 이미지 분석의 발전, 그리고 화합물 특성 평가, 표적 식별, 독성 평가 분야에서 셀 페인팅의 응용 확대에 의해 주도되고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법 및 범위
제2장 요약
제3장 시장 : 변수, 동향, 범위
- 시장 계보 전망
- 시장 역학
- 업계 분석 도구
제4장 셀 페인팅 시장 : 제품 및 서비스별 비즈니스 분석
- 셀 페인팅 시장 : 제품 및 서비스별 동향 분석
- 시약 및 소모품
- 장비
- 소프트웨어 및 계산 도구
- 서비스
- 기타
제5장 셀 페인팅 시장 : 기술별 비즈니스 분석
- 셀 페인팅 시장 : 기술별 동향 분석
- 하이컨텐츠 이미징
- 다중 형광 이미징
- 이미지 분석
- 인공지능·머신러닝
- 데이터 분석
제6장 셀 페인팅 시장 : 용도별 비즈니스 분석
- 셀 페인팅 시장 : 용도별 동향 분석
- 신약 개발
- 독성학 및 안전성 평가
- 질환 모델링 및 기전 생물학
- 기능 유전체학 및 바이오마커 발굴
- 기타 용도
제7장 셀 페인팅 시장 : 세포 유형별 비즈니스 분석
- 셀 페인팅 시장 : 세포 유형별 동향 분석
- 암 세포주
- 1세대 배양 세포
- 줄기세포 및 iPS 세포
- 면역세포
- 신경세포
- 기타 세포 유형
제8장 셀 페인팅 시장 : 최종 용도별 비즈니스 분석
- 셀 페인팅 시장 : 최종 용도별 동향 분석
- 제약 및 생명공학 기업
- 수탁 연구 기관
- 학술 연구 기관
- 기타 최종 사용자
제9장 셀 페인팅 시장 : 지역별 비즈니스 분석
- 셀 페인팅 시장 점유율: 지역별, 2025년-2033년
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
- 라틴아메리카
- 브라질
- 아르헨티나
- 중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트
제10장 경쟁 현황
- 기업 분류
- 기업 점유율 및 포지셔닝 분석, 2025년
- 전략 매핑
- 기업 프로파일 목록
- Thermo Fisher Scientific Inc.
- Revvity
- Charles River Laboratories
- Evotec
- Molecular Devices, LLC.
- Evident（Olympus）
- Nikon Corporation
- Bio-Rad Laboratories, Inc.
- Tecan Trading AG
- Merck KGaA
- Bruker
Cell Painting Market Summary
The global cell painting market size was valued at USD 850.7 million in 2025 and is projected to grow from USD 959.6 million in 2026 to USD 2,359.4 million by 2033, at a CAGR of 13.7% from 2026 to 2033. The market in North America dominated with a revenue share of 39.6% in 2025. The market growth is driven by increasing adoption of high-content phenotypic profiling, advances in artificial intelligence and image analysis, and expanding applications of cell painting in compound characterization, target identification, and toxicity assessment.
Global Cell Painting Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell painting market report based on product & services, technology, application, cell type, end use, and region:
- Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
- Reagents & Consumables
- Instruments
- Software & Computational Tools
- Services
- Others
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- High-Content Imaging
- Multiplexed Fluorescence Imaging
- Image Analysis
- Artificial Intelligence & Machine Learning
- Data Analytics
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Drug Discovery & Development
- Toxicology & Safety Assessment
- Disease Modeling & Mechanistic Biology
- Functional Genomics & Biomarker Discovery
- Other Applications
- Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
- Cancer Cell Lines
- Primary Cells
- Stem Cells & iPSCs
- Immune Cells
- Neuronal Cells
- Other Cell Types
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Research Institutes
- Other End Users
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Product & Services Segment
- 1.1.1.2. Technology Segment
- 1.1.1.3. Application Segment
- 1.1.1.4. Cell Type Segment
- 1.1.1.5. End Use Segment
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Use of Cell Painting in Drug Discovery and Toxicity Screening
- 3.2.1.2. Growing Demand for Automated High-Throughput Cellular Analysis
- 3.2.1.3. Increasing Use of Cell Painting for Toxicity and Safety Assessment
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Availability of Alternative High-Content Screening Technologies
- 3.2.2.2. High Data Processing and Analysis Requirements
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
- 3.3.2.6. Environmental landscape
- 3.3.1. Porter's Five Forces Analysis
Chapter 4. Cell Painting Market: Product & Services Business Analysis
- 4.1. Segment Dashboard
- 4.2. Cell Painting Market: Product & Services Movement Analysis
- 4.3. Reagents & Consumables
- 4.3.1. Reagents & Consumables Market, 2021-2033 (USD Million)
- 4.4. Instruments
- 4.4.1. Instruments Market, 2021-2033 (USD Million)
- 4.5. Software & Computational Tools
- 4.5.1. Software & Computational Tools Market, 2021-2033 (USD Million)
- 4.6. Services
- 4.6.1. Services Market, 2021-2033 (USD Million)
- 4.7. Others
- 4.7.1. Others Market, 2021-2033 (USD Million)
Chapter 5. Cell Painting Market: Technology Business Analysis
- 5.1. Segment Dashboard
- 5.2. Cell Painting Market: Technology Movement Analysis
- 5.3. High-Content Imaging
- 5.3.1. High-Content Imaging Market, 2021-2033 (USD Million)
- 5.4. Multiplexed Fluorescence Imaging
- 5.4.1. Multiplexed Fluorescence Imaging Market, 2021-2033 (USD Million)
- 5.5. Image Analysis
- 5.5.1. Image Analysis Market, 2021-2033 (USD Million)
- 5.6. Artificial Intelligence & Machine Learning
- 5.6.1. Artificial Intelligence & Machine Learning Market, 2021-2033 (USD Million)
- 5.7. Data Analytics
- 5.7.1. Data Analytics Market, 2021-2033 (USD Million)
Chapter 6. Cell Painting Market: Application Business Analysis
- 6.1. Segment Dashboard
- 6.2. Cell Painting Market: Application Movement Analysis
- 6.3. Drug Discovery & Development
- 6.3.1. Drug Discovery & Development Market, 2021-2033 (USD Million)
- 6.4. Toxicology & Safety Assessment
- 6.4.1. Toxicology & Safety Assessment Market, 2021-2033 (USD Million)
- 6.5. Disease Modeling & Mechanistic Biology
- 6.5.1. Disease Modeling & Mechanistic Biology Market, 2021-2033 (USD Million)
- 6.6. Functional Genomics & Biomarker Discovery
- 6.6.1. Functional Genomics & Biomarker Discovery Market, 2021-2033 (USD Million)
- 6.7. Other Applications
- 6.7.1. Other Applications Market, 2021-2033 (USD Million)
Chapter 7. Cell Painting Market: Cell Type Business Analysis
- 7.1. Segment Dashboard
- 7.2. Cell Painting Market: Cell Type Movement Analysis
- 7.3. Cancer Cell Lines
- 7.3.1. Cancer Cell Lines Market, 2021-2033 (USD Million)
- 7.4. Primary Cells
- 7.4.1. Primary Cells Market, 2021-2033 (USD Million)
- 7.5. Stem Cells & iPSCs
- 7.5.1. Stem Cells & iPSCs Market, 2021-2033 (USD Million)
- 7.6. Immune Cells
- 7.6.1. Immune Cells Market, 2021-2033 (USD Million)
- 7.7. Neuronal Cells
- 7.7.1. Neuronal Cells Market, 2021-2033 (USD Million)
- 7.8. Other Cell Types
- 7.8.1. Other Cell Types Market, 2021-2033 (USD Million)
Chapter 8. Cell Painting Market: End Use Business Analysis
- 8.1. Segment Dashboard
- 8.2. Cell Painting Market: End Use Movement Analysis
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Pharmaceutical & Biotechnology Companies Market, 2021-2033 (USD Million)
- 8.4. Contract Research Organizations
- 8.4.1. Contract Research Organizations Market, 2021-2033 (USD Million)
- 8.5. Academic & Research Institutes
- 8.5.1. Academic & Research Institutes Market, 2021-2033 (USD Million)
- 8.6. Other End Users
- 8.6.1. Other End Users Market, 2021-2033 (USD Million)
Chapter 9. Cell Painting Market: Regional Business Analysis
- 9.1. Cell Painting Market Share By Region, 2025 & 2033
- 9.2. North America
- 9.2.1. North America Cell Painting Market, 2021-2033 (USD Million)
- 9.2.2. U.S.
- 9.2.2.1. Key Country Dynamics
- 9.2.2.2. Competitive Scenario
- 9.2.2.3. Regulatory Framework
- 9.2.2.4. U.S. Cell Painting Market, 2021-2033 (USD Million)
- 9.2.3. Canada
- 9.2.3.1. Key Country Dynamics
- 9.2.3.2. Competitive Scenario
- 9.2.3.3. Regulatory Framework
- 9.2.3.4. Canada Cell Painting Market, 2021-2033 (USD Million)
- 9.2.4. Mexico
- 9.2.4.1. Key Country Dynamics
- 9.2.4.2. Competitive Scenario
- 9.2.4.3. Regulatory Framework
- 9.2.4.4. Mexico Cell Painting Market, 2021-2033 (USD Million)
- 9.3. Europe
- 9.3.1. Europe Cell Painting Market, 2021-2033 (USD Million)
- 9.3.2. UK
- 9.3.2.1. Key Country Dynamics
- 9.3.2.2. Competitive Scenario
- 9.3.2.3. Regulatory Framework
- 9.3.2.4. UK Cell Painting Market, 2021-2033 (USD Million)
- 9.3.3. Germany
- 9.3.3.1. Key Country Dynamics
- 9.3.3.2. Competitive Scenario
- 9.3.3.3. Regulatory Framework
- 9.3.3.4. Germany Cell Painting Market, 2021-2033 (USD Million)
- 9.3.4. France
- 9.3.4.1. Key Country Dynamics
- 9.3.4.2. Competitive Scenario
- 9.3.4.3. Regulatory Framework
- 9.3.4.4. France Cell Painting Market, 2021-2033 (USD Million)
- 9.3.5. Italy
- 9.3.5.1. Key Country Dynamics
- 9.3.5.2. Competitive Scenario
- 9.3.5.3. Regulatory Framework
- 9.3.5.4. Italy Cell Painting Market, 2021-2033 (USD Million)
- 9.3.6. Spain
- 9.3.6.1. Key Country Dynamics
- 9.3.6.2. Competitive Scenario
- 9.3.6.3. Regulatory Framework
- 9.3.6.4. Spain Cell Painting Market, 2021-2033 (USD Million)
- 9.3.7. Denmark
- 9.3.7.1. Key Country Dynamics
- 9.3.7.2. Competitive Scenario
- 9.3.7.3. Regulatory Framework
- 9.3.7.4. Denmark Cell Painting Market, 2021-2033 (USD Million)
- 9.3.8. Sweden
- 9.3.8.1. Key Country Dynamics
- 9.3.8.2. Competitive Scenario
- 9.3.8.3. Regulatory Framework
- 9.3.8.4. Sweden Cell Painting Market, 2021-2033 (USD Million)
- 9.3.9. Norway
- 9.3.9.1. Key Country Dynamics
- 9.3.9.2. Competitive Scenario
- 9.3.9.3. Regulatory Framework
- 9.3.9.4. Norway Cell Painting Market, 2021-2033 (USD Million)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific Cell Painting Market, 2021-2033 (USD Million)
- 9.4.2. Japan
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Competitive Scenario
- 9.4.2.3. Regulatory Framework
- 9.4.2.4. Japan Cell Painting Market, 2021-2033 (USD Million)
- 9.4.3. China
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Competitive Scenario
- 9.4.3.3. Regulatory Framework
- 9.4.3.4. China Cell Painting Market, 2021-2033 (USD Million)
- 9.4.4. India
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Competitive Scenario
- 9.4.4.3. Regulatory Framework
- 9.4.4.4. India Cell Painting Market, 2021-2033 (USD Million)
- 9.4.5. Australia
- 9.4.5.1. Key Country Dynamics
- 9.4.5.2. Competitive Scenario
- 9.4.5.3. Regulatory Framework
- 9.4.5.4. Australia Cell Painting Market, 2021-2033 (USD Million)
- 9.4.6. Thailand
- 9.4.6.1. Key Country Dynamics
- 9.4.6.2. Competitive Scenario
- 9.4.6.3. Regulatory Framework
- 9.4.6.4. Thailand Cell Painting Market, 2021-2033 (USD Million)
- 9.4.7. South Korea
- 9.4.7.1. Key Country Dynamics
- 9.4.7.2. Competitive Scenario
- 9.4.7.3. Regulatory Framework
- 9.4.7.4. South Korea Cell Painting Market, 2021-2033 (USD Million)
- 9.5. Latin America
- 9.5.1. Latin America Cell Painting Market, 2021-2033 (USD Million)
- 9.5.2. Brazil
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Competitive Scenario
- 9.5.2.3. Regulatory Framework
- 9.5.2.4. Brazil Cell Painting Market, 2021-2033 (USD Million)
- 9.5.3. Argentina
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Competitive Scenario
- 9.5.3.3. Regulatory Framework
- 9.5.3.4. Argentina Cell Painting Market, 2021-2033 (USD Million)
- 9.6. MEA
- 9.6.1. MEA Cell Painting Market, 2021-2033 (USD Million)
- 9.6.2. South Africa
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Competitive Scenario
- 9.6.2.3. Regulatory Framework
- 9.6.2.4. South Africa Cell Painting Market, 2021-2033 (USD Million)
- 9.6.3. Saudi Arabia
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Competitive Scenario
- 9.6.3.3. Regulatory Framework
- 9.6.3.4. Saudi Arabia Cell Painting Market, 2021-2033 (USD Million)
- 9.6.4. UAE
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Competitive Scenario
- 9.6.4.3. Regulatory Framework
- 9.6.4.4. UAE Cell Painting Market, 2021-2033 (USD Million)
- 9.6.5. Kuwait
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Competitive Scenario
- 9.6.5.3. Regulatory Framework
- 9.6.5.4. Kuwait Cell Painting Market, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Company Categorization
- 10.2. Company Market Share/ Position Analysis, 2025
- 10.3. Strategy Mapping
- 10.4. Company Profiles/Listing
- 10.4.1. Thermo Fisher Scientific Inc.
- 10.4.1.1. Overview
- 10.4.1.2. Financial Performance
- 10.4.1.3. Product Benchmarking
- 10.4.1.4. Strategic Initiatives
- 10.4.2. Revvity
- 10.4.2.1. Overview
- 10.4.2.2. Financial Performance
- 10.4.2.3. Product Benchmarking
- 10.4.2.4. Strategic Initiatives
- 10.4.3. Charles River Laboratories
- 10.4.3.1. Overview
- 10.4.3.2. Financial Performance
- 10.4.3.3. Product Benchmarking
- 10.4.3.4. Strategic Initiatives
- 10.4.4. Evotec
- 10.4.4.1. Overview
- 10.4.4.2. Financial Performance
- 10.4.4.3. Product Benchmarking
- 10.4.4.4. Strategic Initiatives
- 10.4.5. Molecular Devices, LLC.
- 10.4.5.1. Overview
- 10.4.5.2. Financial Performance
- 10.4.5.3. Product Benchmarking
- 10.4.5.4. Strategic Initiatives
- 10.4.6. Evident (Olympus)
- 10.4.6.1. Overview
- 10.4.6.2. Financial Performance
- 10.4.6.3. Product Benchmarking
- 10.4.6.4. Strategic Initiatives
- 10.4.7. Nikon Corporation
- 10.4.7.1. Overview
- 10.4.7.2. Financial Performance
- 10.4.7.3. Product Benchmarking
- 10.4.7.4. Strategic Initiatives
- 10.4.8. Bio-Rad Laboratories, Inc.
- 10.4.8.1. Overview
- 10.4.8.2. Financial Performance
- 10.4.8.3. Product Benchmarking
- 10.4.8.4. Strategic Initiatives
- 10.4.9. Tecan Trading AG
- 10.4.9.1. Overview
- 10.4.9.2. Financial Performance
- 10.4.9.3. Product Benchmarking
- 10.4.9.4. Strategic Initiatives
- 10.4.10. Merck KGaA
- 10.4.10.1. Overview
- 10.4.10.2. Financial Performance
- 10.4.10.3. Product Benchmarking
- 10.4.10.4. Strategic Initiatives
- 10.4.11. Bruker
- 10.4.11.1. Overview
- 10.4.11.2. Financial Performance
- 10.4.11.3. Product Benchmarking
- 10.4.11.4. Strategic Initiatives
- 10.4.1. Thermo Fisher Scientific Inc.
